ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,231Medicare Part D Prescriptions Filled, Including Refills

Rank: 70 out of 586

$285K Total Retail Price of All Prescriptions

Rank: 116 out of 586

273 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 273 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 273 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 5,416 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
OMEPRAZOLE 338 317 1 3
LEVOTHYROXINE SODIUM 243 213 2 2
HYDROCODONE-ACETAMINOPHEN 200 173 S3 3 5
LISINOPRIL 194 167 4 4
SIMVASTATIN 186 170 5 1
METFORMIN HCL 169 137 6 6
LOSARTAN POTASSIUM 155 145 7 18
FUROSEMIDE 144 141 8 9
FLUOXETINE HCL 130 90 9 24
POTASSIUM CHLORIDE 115 115 10 14
CITALOPRAM HBR 112 105 11 12
WARFARIN SODIUM 107 104 12 13
METOPROLOL SUCCINATE 106 102 13 19
AMLODIPINE BESYLATE 105 101 14 7
BUPROPION HCL SR 105 82 14 106
GABAPENTIN 92 66 16 11
ZOLPIDEM TARTRATE 87 61 17 8
VENLAFAXINE HCL ER 85 69 18 88
TAMSULOSIN HCL 85 78 18 27
HYDROCHLOROTHIAZIDE 84 78 20 10
TRAZODONE HCL 82 53 21 20
FENOFIBRATE 78 77 22 39
POLYETHYLENE GLYCOL 3350 77 61 23 47
QUETIAPINE FUMARATE 76 52 24 50
SERTRALINE HCL 68 48 25 21
CYCLOBENZAPRINE HCL 65 36 R 26 60
ATENOLOL 63 62 27 34
DOXAZOSIN MESYLATE 62 56 28 94
GLIMEPIRIDE 59 57 29 38
AMITRIPTYLINE HCL 57 48 R 30 62
FINASTERIDE 55 55 31 84
CLOPIDOGREL 54 53 32 71
ATORVASTATIN CALCIUM 53 52 33 17
DILTIAZEM 24HR ER 52 52 34 235
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 20, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.